Morgan Stanley raises Emerson target to $145, keeps Underweight

On October 19, Morgan Stanley analyst Chris Snyder raised his target from $135 to $145 and maintained Underweight. EMR closed October 30 at $164.94, down 3.40% that day; the source did not attribute the move to company-specific news.